No easy road to outsmart cancer

1 July 2015 0

Hopes of greatly speeding up the evaluation of new therapies by using tumour response to a short course of neoadjuvant treatment as a surrogate for clinical benefit have proved false and the sooner we recognise [more]

UA-77507851-1